ArticlePsychopharmacology2009
Blockade of the acquisition, but not expression, of associative learning by pre-session intra-amygdala R(+) 7-OH-DPAT.
Article in Psychopharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 9 citations in OpenAlex.
- Serotonin at the level of the amygdala and orbitofrontal cortex modulates distinct aspects of positive emotion in primates.The international journal of neuropsychopharmacology · 2012Article
- Opposing roles of nucleus accumbens core and shell dopamine in the modulation of limbic information processing.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011Article
- Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behavior.Behavioural brain research · 2010Article
- Role of the mesoamygdaloid dopamine projection in emotional learning.Psychopharmacology · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
rationaleTwo issues were addressed regarding the effects of amygdala dopamine manipulations on associative learning: first, an apparent contradiction between the effects of post- vs. pre-session dopaminergic manipulations and second, the ability of dopaminergic infusions to affect association formation vs. its expression following extended training.
objectivesThe ability of pre-session infusions of a dopamine receptor agonist (R(+) 7-OH-DPAT) to inhibit acquisition of a conditioned approach response was examined and compared with the same manipulation following overtraining. Further experiments extended these findings. MATERIALS AND
methodsExperiment 1 infused pre-session intra-amygdala R(+) 7-OH-DPAT (0, 0.1, 1 nmol) during conditioned approach acquisition. Experiment 2 applied pre-session intra-amygdala R(+) 7-OH-DPAT (0, 0.01, 0.1, 1 nmol) during expression of the same response, once well learned. Experiment 3 required the inhibition of a conditioned approach response following unconditioned stimulus (US) removal. Experiment 4 examined the ability of animals with prior drug experience to acquire a conditioned response to a novel stimulus.
resultsExperiments 1-3 showed that pre-session amygdala R(+) 7-OH-DPAT impaired acquisition of either excitatory or inhibitory conditioned responding, but was ineffective following overtraining. Drug-induced impairments in acquisition of a specific conditioned stimulus (CS)-US relationship continued well beyond the cessation of drug treatment, but were found not to transfer to an alternate CS in Experiment 4.
conclusionsPre-session dopamine receptor activation within the amygdala may impair the acquisition, but not expression, of CS-US associations. Enhanced learning reported earlier following post-session dopamine receptor activation may occur indirectly through reduced interference with the consolidation of recent learning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.